GW Pharmaceuticals Plc (GWPH)

183.65
1.04 0.56
NASDAQ : Health Technology
Prev Close 184.69
Open 185.19
Day Low/High 181.50 / 187.69
52 Wk Low/High 90.14 / 196.00
Volume 315.48K
Avg Volume 471.10K
Exchange NASDAQ
Shares Outstanding 30.72M
Market Cap 5.67B
EPS -10.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Get Out Your Shopping List: Cramer's 'Mad Money' Recap (Monday 5/6/19)

Get Out Your Shopping List: Cramer's 'Mad Money' Recap (Monday 5/6/19)

Jim Cramer's take on tariff troubles? Break out your stock shopping list and buy domestic companies that are doing well.

Take-Two Interactive, Lennox International: 'Mad Money' Lightning Round

Take-Two Interactive, Lennox International: 'Mad Money' Lightning Round

Jim Cramer weighs in on Take-Two Interactive, Lennox International, Nabors Industries, CH Robinson Worldwide, The Blackstone Group, FedEx and more.

You Don't Have to Swing for the Fences With Every Investment in Small Caps

You Don't Have to Swing for the Fences With Every Investment in Small Caps

The way I do that is by using buy-write option strategies.

9 Speculative Plays for Investors Wanting Cannabis Exposure

9 Speculative Plays for Investors Wanting Cannabis Exposure

Five top marijuana stocks and four CBD plays in this speculative space.

2 Hemp Stocks for Investors Looking for Something Different

2 Hemp Stocks for Investors Looking for Something Different

You may want to check out GW Pharmaceuticals and Elixinol Global Limited.

Melius Research Launches Cannabis Industry Coverage

Melius Research Launches Cannabis Industry Coverage

In its first report on cannabis companies, Melius says prices are high.

The Ones That Got Away: Cramer's 'Mad Money' Recap (Thursday 2/28/19)

The Ones That Got Away: Cramer's 'Mad Money' Recap (Thursday 2/28/19)

Jim Cramer lists the great stocks and the obvious winners he wishes he had talked about more.

GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock

GW Pharmaceuticals Is Ready to Rally More: How to Trade This Cannabis Stock

My trading strategy for GWPH whether you are currently long or want to be.

Jim Cramer: My Best Stock Picks for Cannabis and China

Jim Cramer: My Best Stock Picks for Cannabis and China

And why I won't recommend any other stocks in these markets, right now.

What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)

What's Keeping You Up?: Cramer's 'Mad Money' Recap (Wednesday 2/27/19)

Jim Cramer says if you focus on what's going right, you'll sleep better and do a lot better with your money, too.

Chart of the Week: GW Pharmaceuticals

GWPH is ready to float higher after some sideways consolidation.

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Power of Positives: Cramer's 'Mad Money' Recap (Thursday 1/17/19)

Jim Cramer talks about how this market is taking its cues from the positives, and shrugging off the negatives.

Brinks, Medtronic, Fiat Chrysler: 'Mad Money' Lightning Round

Brinks, Medtronic, Fiat Chrysler: 'Mad Money' Lightning Round

Jim Cramer weighs in on Brinks, Sangamo Biosciences, Medtronic, Fiat Chrysler, GW Pharmaceuticals, EPR Properties.

Why Canada Rules as a Haven for Listing Cannabis Companies

Why Canada Rules as a Haven for Listing Cannabis Companies

The main reason most cannabis-related concerns head north to list their shares is banking.

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Farm Bill's Hemp Legalization Is Poised to Boost These 2 Stocks

Despite the current stock market, investors are still looking for ways to play the new legalization of hemp.

Kali-Extracts, Inc. Releases Preclinical Research Study Results On Therapy For Respiratory Disease Driving $11 Billion Treatment Market

Kali-Extracts, Inc. Releases Preclinical Research Study Results On Therapy For Respiratory Disease Driving $11 Billion Treatment Market

DALLAS, December 19, 2018 /PRNewswire/ -- Kali, Inc. (Kali, Inc.

How to Invest in Cannabis - In Its Many Forms

How to Invest in Cannabis - In Its Many Forms

As cannabis becomes more and more legal, investors have started to wonder what that means for them.

GW Pharmaceuticals Is Poised to Rally to New Highs, Risk Defined

GW Pharmaceuticals Is Poised to Rally to New Highs, Risk Defined

A potential great pipeline but let's check the charts.

A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18)

A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18)

Jim Cramer's been saying that that if the Fed or the president blink in their wars against inflation and China you could have an up day. That's what we got.

What Are the Side Effects of Marijuana? Experts Explain in 2018

What Are the Side Effects of Marijuana? Experts Explain in 2018

As cannabis becomes increasingly legalized in a recreational and medicinal capacity, what actually are the side effects of marijuana? Experts told TheStreet the things you need to know about how the plant affects you.

Canopy Growth and 2 Other Pot Stocks to Buy as Canada Legalizes Cannabis

Canopy Growth and 2 Other Pot Stocks to Buy as Canada Legalizes Cannabis

These names should stoke up your portfolio.

Check Out These Stocks as Canada Is About to Be Smokin' Hot

Check Out These Stocks as Canada Is About to Be Smokin' Hot

On Wednesday, Canada becomes the first major economy to legalize the recreational use of cannabis.

Canopy Growth and 4 Other Cannabis Stocks That Look Good Here

Canopy Growth and 4 Other Cannabis Stocks That Look Good Here

These stocks offer some diversification or unique features in the legal-weed space.

Some Cannabis Stocks Rise as DEA Rethinks CBD Stance

Some Cannabis Stocks Rise as DEA Rethinks CBD Stance

The DEA will now classify certain drug products to containing cannabidiol as schedule V.

Legalized Recreational Marijuana Won't Kill Medical Marijuana

Legalized Recreational Marijuana Won't Kill Medical Marijuana

Sales trends and the potential for stronger versions of prescription cannabis offer medical marijuana providers hope.

CBD Doesn't Get You High, But Could Someday Eclipse the Entire Pot Industry

CBD Doesn't Get You High, But Could Someday Eclipse the Entire Pot Industry

Cannabidiol, or CBD, is a cannabis extract that's used to treat everything from pain to opiate addiction to PTSD. It doesn't get you high -- but advocates say that's the reason that CBD could soon eclipse the multibillion-dollar pot industry.

History of Marijuana: Origins, Legality and What's Happening in 2018

History of Marijuana: Origins, Legality and What's Happening in 2018

Marijuana has gone from an ancient medicinal herb to an edible gummy bear -- but how has the plant's tumultuous past impacted its future market?

GW Pharmaceuticals Reaches Analyst Target Price

GW Pharmaceuticals Reaches Analyst Target Price

In recent trading, shares of GW Pharmaceuticals plc have crossed above the average analyst 12-month target price of $168.88, changing hands for $170.10/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.